The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
Thomas van Doeveren(Erasmus MC Cancer Institute), Joost L. Boormans(Erasmus MC), Harmen J.G. van de Werken(Erasmus MC), Job van Riet(Erasmus MC Cancer Institute), Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Antoine G. van der Heijden(Radboud University Nijmegen), Andrew S. Mason(University of York), Charlotte S. Voskuilen(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Kees Hendricksen(The Netherlands Cancer Institute), Geert J.L.H. van Leenders(Erasmus MC Cancer Institute), Isabelle C. Meijssen(Erasmus MC Cancer Institute), Bas W.G. van Rhijn(The Netherlands Cancer Institute), Hendrikus J. Dubbink(Erasmus MC), Angelique C. van der Made(Erasmus MC Cancer Institute), Winand N.M. Dinjens(Erasmus MC)
Cited by 24
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493